Get the Stockscreener App
282.98
6.70%
-20.33
After Hours:
283.00
0.02
+0.01%
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $282.98, with a volume of 5.47M.
It is down -6.70% in the last 24 hours and up +2.85% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
See More
Previous Close:
$303.31
Open:
$275
24h Volume:
5.47M
Relative Volume:
2.83
Market Cap:
$78.71B
Revenue:
$229.75B
Net Income/Loss:
$3.04B
P/E Ratio:
26.70
EPS:
10.6
Net Cash Flow:
$5.18B
1W Performance:
-4.07%
1M Performance:
+2.85%
6M Performance:
-19.78%
1Y Performance:
-5.34%
1-Day Range:
$268.99
$282.99
1-Week Range:
$268.99
$308.64
52-Week Range:
$262.03
$370.82
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CI
Cigna Group
|
282.98 | 78.71B | 229.75B | 3.04B | 5.18B | 10.60 |
|
UNH
Unitedhealth Group Inc
|
545.57 | 503.79B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
399.32 | 92.61B | 176.81B | 5.98B | 4.55B | 25.60 |
|
CVS
Cvs Health Corp
|
56.82 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
|
HUM
Humana Inc
|
296.91 | 35.75B | 115.01B | 1.36B | -4.34B | 11.29 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Health Care Up as Quest Diagnostics Surges, Cigna Falls -- Health Care Roundup - MarketWatch
Cigna Group stock underperforms Thursday when compared to competitors - MarketWatch
Cigna (NYSE:CI) Surprises With Q4 Sales - Yahoo Finance UK
The Cigna Group Reports Fourth Quarter and Full Year 2024 Results - citybiz
Cigna (CI) Stock Declines Due to Earnings Miss and Rising Costs - GuruFocus.com
Why Cigna Stock Is Plummeting Today - The Motley Fool
Cigna’s lower earnings reveal how sick American workers are - STAT
Cigna Group (CI) Q4 2024 Earnings Call Transcript - AOL
Sector Update: Health Care Stocks Gain in Afternoon Trading -January 30, 2025 at 02:08 pm EST - Marketscreener.com
Cigna's 27% Revenue Increase in 2024 and the Outlook on 2025 - Managed Healthcare Executive
Why Cigna (CI) Stock Is Down Today - Yahoo Finance
Cigna Q4 Earnings Miss Estimates on Decline in Medical Membership - Yahoo Finance
Cigna pledges changes to pharmacy, medical benefits following ‘messy’ close to 2024 - Healthcare Dive
Cigna quarterly profit hit by higher medical costs, shares tumble - MSN
Cigna to ‘listen to the public narrative,’ promises pharmacy benefit reforms - Insurance News Net
Cigna Plunges As Catastrophic Medical Costs Hurt Profit - Yahoo Finance
Cigna to spend $150M to improve prior auth, patient advocacy: CEO - Modern Healthcare
Cigna posts Q4 earnings miss, hit by rising medical costs - Yahoo Finance
Cigna Shares Drop Amid Rising Medical Costs in Q4News and Statistics - IndexBox, Inc.
Cigna (CI) Shares Plummet Amid Rising Healthcare Claims Costs - GuruFocus.com
Cigna Q4 profit takes hit due to medical costs - Healthcare Finance News
The Cigna Group Declares Quarterly Cash Dividend, Payable on March 20, 2025 -January 30, 2025 at 06:00 am EST - Marketscreener.com
Cigna missed Wall Street estimates as medical costs rise - Sherwood News
Cigna stock falls after 4Q earnings miss forecasts; higher medical costs to blame - Hartford Business Journal
Raymond James maintains CIGNA stock Strong Buy, $415 target - Investing.com
A Closer Look at Cigna's Options Market Dynamics - Benzinga
Cigna Stock Dives After Earnings. Here’s What Went Wrong. - Barron's
Cigna Signs $2.9 Million Class Deal in Covid Testing Cost Suit - Bloomberg Law
BofA maintains CIGNA stock Buy rating, $420 price target - Investing.com
Cigna (CI) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Sector Update: Health Care Stocks Rise Pre-Bell Thursday -January 30, 2025 at 09:20 am EST - Marketscreener.com
Cigna tumbles after medical costs hit quarterly profit - Modern Healthcare
Raymond James Reiterates Strong Buy Rating on CIGNA (CI) - StreetInsider.com
Cigna plans to limit out-of-pocket drug costs for U.S. patients - Fortune
BofA on CIGNA (CI): 'Quarter and outlook disappoint, valuation pressured' - StreetInsider.com
Cortland Associates Inc. MO Has $35.05 Million Stock Position in The Cigna Group (NYSE:CI) - MarketBeat
Highland Capital Management LLC Raises Holdings in The Cigna Group (NYSE:CI) - MarketBeat
The Cigna Group (NYSE:CI) Issues FY 2025 Earnings Guidance - MarketBeat
Cigna set to close $3.7B MA sale to HCSC in Q1 - Fierce healthcare
Cigna Raises Quarterly Dividend by 7.9%, Boosts Buyback Program by $6 Billion - MarketWatch
Cigna falls short of Q4 profit estimates due to higher medical costs - Business Standard
Cigna: Q4 Earnings Snapshot - San Antonio Express-News
Cigna (CI) Lags Q4 Earnings Estimates - Yahoo Finance
Cigna stock drops after Q4 earnings miss (CI:NYSE) - Seeking Alpha
Cigna Group Reports Q4 EPS of $5.13, Missing Estimates; Revenue Surpasses Expectations at $247.1 Billion - GuruFocus.com
Cigna Group Q4 Adjusted Earnings Decline, Revenue Increases; Issues 2025 Guidance - Marketscreener.com
Cigna shares tumble as Q4 earnings miss, 2025 outlook disappoints - Investing.com
Cigna: Q4 Earnings Snapshot -January 30, 2025 at 06:20 am EST - Marketscreener.com
Cigna Group (NYSE: CI) Falls Short of Q4 Expected EPS - The Tokenist
Cigna's Profits Dip As Medical Costs Rise Beyond Expectations - Finimize
Earnings Flash (CI) Cigna Group Posts Q4 Adjusted EPS $6.64, vs. FactSet Est of $7.82 - Marketscreener.com
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.24%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):